Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Appointment of Joint Broker

1st Oct 2018 07:00

RNS Number : 4180C
Feedback PLC
01 October 2018
 

 

1 October 2018

 

Feedback plc

 

Appointment of Joint Broker

 

Feedback plc (AIM: FDBK, 'Feedback' or the 'Company'), the specialist medical imaging technology company, announces the appointment of Stanford Capital Partners Limited as its Joint Broker with immediate effect.

 

-ENDS-

 

 

For further information, please contact:

 

Feedback plc

Alastair Riddell, Executive Chairman

 

+44 (0)1954 718072

[email protected]

Allenby Capital Limited (Nominated Adviser and Joint Broker)

David Worlidge / Asha Chotai

 

+44 (0)20 3328 5656

Peterhouse Corporate Finance Ltd (Joint Broker)

Lucy Williams / Duncan Vasey

 

Stanford Capital Partners Limited

Patrick Claridge / John Howes

 

+44 (0)20 7469 0936

 

 

+44 (0)203 815 8880

Instinctif Partners

Melanie Toyne Sewell / Rozi Morris

+44 (0)20 7457 2020

[email protected]

 

 

Notes to editors

 

About Feedback plc

Feedback plc is a specialist medical imaging technology company. It develops software and systems that provide innovative techniques and improved workflows for practitioners involved in medical research and treating patients. TexRAD®, the Company's patented quantitative image texture analysis technology, has the potential to assist clinicians in diagnosis, prognosis and treatment of patients with cancer and is currently installed in over 50 of the world's leading research institutions across Europe, North America, Asia and Australasia. The Cadran platform provides a suite of medical imaging tools for decision support. The Cadran range includes the picture archiving communication system (PACS) to provide decision support for scan analysis, diagnostic workstations which provide secure remote access to view scans on demand, and products to securely share and transport patient data.  

For more information visit www.fbk.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
APPEAKNPAFDPEFF

Related Shares:

Feedback
FTSE 100 Latest
Value8,608.48
Change-26.32